Am J Ophthalmol

1. HE L, Guo X, Yong Z, Zha Y, et al
   Choroidal-Derived Intraretinal Neovascularization Compensates for Diabetic Retinopathy Ischemia via Dual-Pathway Remodeling Post-PRP.
   Am J Ophthalmol. 2025 Nov 9:S0002-9394(25)00587.
   

   >> Share

   
   

   
   Angiology

2. ENGIN M, Aydin C, Ari H
   Letter: Reperfusion of Proximal Left Circumflex Artery in Diabetic Chronic Total Occlusion Patients.
   Angiology. 2025 Nov 12:33197251395828. doi: 10.1177/00033197251395828.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

3. LARANJEIRA EPP, da Silva DHM, da Silva Nascimento FG, Martins AB, et al
   Canavalia brasiliensis lectin attenuates diabetes endothelial dysfunction in rats: structural basis and implication of muscarinic/insulin receptors.
   Biochem Biophys Res Commun. 2025;791:152929.
   

   >> Share

   
   
4. HUANG C, Sun Y, Wu J, Wu D, et al
   Down-regulation of KMT2D mitigates neointimal hyperplasia following carotid artery injury in diabetic rats.
   Biochem Biophys Res Commun. 2025;791:152837.
   

   >> Share

   
   

   
   BMC Ophthalmol

5. SHARMA S, Madan VV, Banerjee S
   Comparative study of corneal endothelial morphology and central corneal thickness in diabetic and non-diabetic patients at tertiary care centre.
   BMC Ophthalmol. 2025;25:640.
   

   >> Share

   
   

   
   BMJ

6. LOGAN M
   Trump expands visa requirements to include diabetes and obesity.
   BMJ. 2025;391:r2400.
   

   >> Share

   
   

   
   Diabet Med

7. ZUO C, Chen H, Lu X, Cheng J, et al
   VEGFA-centric angiogenic genetic variants drive hypertension and dyslipidaemia susceptibility in type 2 diabetes mellitus: A multilocus synergistic cohort study.
   Diabet Med. 2025 Nov 12:e70169. doi: 10.1111/dme.70169.
   

   >> Share

   
   
8. ERBASAN E, Aliciaslan M, Erendor F, Dandin O, et al
   Lantidra (donislecel) in type 1 diabetes: An in-depth analysis of pharmacology, clinical effectiveness, safety, and the therapeutic role of the first FDA-approved allogeneic islet cell therapy.
   Diabet Med. 2025 Nov 11:e70168. doi: 10.1111/dme.70168.
   

   >> Share

   
   
9. WILLIS K, Shakespeare R, Chandrasekaran L, Chaudhry U, et al
   What are the perceptions and concerns of people living with diabetes and National Health Service staff around the potential implementation of AI-assisted screening for diabetic eye disease?
   Diabet Med. 2025 Nov 10:e70165. doi: 10.1111/dme.70165.
   

   >> Share

   
   
10. JONES AD, Crossland S, Nixon JE, Siddle HJ, et al
    Comparing plantar shear strain in patients with a previous diabetes-related foot ulcer and those at low risk for ulceration using the STrain Analysis and Mapping of the Plantar Surface (STAMPS) system.
    Diabet Med. 2025 Nov 9:e70164. doi: 10.1111/dme.70164.
    

    >> Share

    
    
11. SNG GGR, Lim GH, Tian KJY, Bee YM, et al
    Trends in admissions for hyperglycaemic emergencies and associated clinical factors in adults with type 2 diabetes in Singapore, 2013-2022.
    Diabet Med. 2025 Nov 9:e70167. doi: 10.1111/dme.70167.
    

    >> Share

    
    

    
    Diabetes

12. AROSEMENA M, Chopra K, Salguero MV, Reyes D, et al
    Obstructive Sleep Apnea, Resting Heart Rate, and Glycemic Variability in Adults With Maturity-Onset Diabetes of the Young.
    Diabetes. 2025 Nov 13:db240787. doi: 10.2337/db24-0787.
    

    >> Share

    
    
13. JING H, Shi M, Wang Y, Cao R, et al
    beta-Hydroxybutyrylation Links Ketone Metabolism to Mitochondrial Remodeling in Diabetic Cardiomyopathy.
    Diabetes. 2025 Nov 10:db250496. doi: 10.2337/db25-0496.
    

    >> Share

    
    

    
    Diabetes Care

14. HALLER MJ, Kanapka L, Monzavi R, Mouse TJ, et al
    INHALE-1: A Multicenter Randomized Trial of Inhaled Technosphere Insulin in Children With Type 1 Diabetes.
    Diabetes Care. 2025 Nov 12:dc251994. doi: 10.2337/dc25-1994.
    

    >> Share

    
    
15. WILSON CS, Falk A, Williams JM, Hilmes M, et al
    Use of Teplizumab to Modulate Stage 2 Type 1 Diabetes in Two Individuals With Autoimmune Polyendocrine Syndrome 1.
    Diabetes Care. 2025 Nov 12:dc251444. doi: 10.2337/dc25-1444.
    

    >> Share

    
    
16. PARK CM, Thanapluetiwong S, Chen X, Oh G, et al
    Sodium-Glucose Cotransporter-2 Inhibitors, Glucagon-Like Peptide-1 Receptor Agonists, and Frailty Progression in Older Adults With Type 2 Diabetes.
    Diabetes Care. 2025 Nov 13:dc251031. doi: 10.2337/dc25-1031.
    

    >> Share

    
    

    
    Diabetes Obes Metab

17. SUN R, Wang Y, Shu H, Li L, et al
    Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial.
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70262.
    

    >> Share

    
    
18. WHARTON S, le Roux CW, Bozkurt B, Platz E, et al
    Baseline characteristics in the SYNCHRONIZE-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes.
    Diabetes Obes Metab. 2025 Nov 11. doi: 10.1111/dom.70263.
    

    >> Share

    
    
19. BOYE KS, Neff LM, Perez-Nieves M, Lage MJ, et al
    Medical events and costs associated with metabolic bariatric surgery among adults with type 2 diabetes: A retrospective, matched cohort study.
    Diabetes Obes Metab. 2025 Nov 11. doi: 10.1111/dom.70226.
    

    >> Share

    
    
20. LIU S, Liu B, Zhang Y, Qiu X, et al
    Longitudinal trajectories of fasting plasma glucose predicting cardiovascular disease risk in Chinese patients with type 2 diabetes under health management.
    Diabetes Obes Metab. 2025 Nov 12. doi: 10.1111/dom.70277.
    

    >> Share

    
    
21. HARLEY M, Rentsch CT, Williamson E, Shah ASV, et al
    Ethnic differences in the comparative effectiveness of second-line type 2 diabetes medications in preventing cardiovascular disease.
    Diabetes Obes Metab. 2025 Nov 12. doi: 10.1111/dom.70273.
    

    >> Share

    
    
22. COLEMAN RL, Adler AI, Clarke PM, McGuire DK, et al
    Estimating the risk of cardiovascular outcomes and all-cause mortality in individuals with type 2 diabetes: Validation of the UKPDS outcomes model using TECOS and EXSCEL data.
    Diabetes Obes Metab. 2025 Nov 12. doi: 10.1111/dom.70280.
    

    >> Share

    
    
23. ANAGNOSTOPOULOU L, Liarakos AL, Ntanasis-Stathopoulos I, Briasoulis A, et al
    Continuous glucose monitoring and microvascular complications in diabetes: Bridging glycemic metrics with clinical outcomes.
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70288.
    

    >> Share

    
    
24. YU W, Chen Y, Yuan M, Liang A, et al
    The global burden of early-onset type 2 diabetes (1990-2050): An age-period-cohort analysis of incidence, disparities, and projections.
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70287.
    

    >> Share

    
    
25. BOSE R, Gupta R
    Letter to the Editor in response to "Management of metabolic dysfunction-associated steatotic liver disease (MASLD)-An expert consensus statement from Indian diabetologists' perspective".
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70284.
    

    >> Share

    
    
26. ANDERSEN ES, Foghsgaard S, Vedtofte L, Pedersen MH, et al
    Five years liraglutide treatment improves glucose tolerance in women with previous gestational diabetes mellitus-Results from a randomised controlled trial.
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70286.
    

    >> Share

    
    
27. THAMMAKOSOL K, Vongtangton P, Numthavaj P, Auttara-Atthakorn A, et al
    Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta-analysis of randomised controlled trials.
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70276.
    

    >> Share

    
    
28. TANG WC, Reynier P, Douros A, Yu OHY, et al
    Sodium glucose co-transporter 2 inhibitors versus dipeptidyl peptidase-4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population-based cohort study.
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70264.
    

    >> Share

    
    
29. SUN F, Zhang M, Pan Q, Shen P, et al
    The association between glycaemic control, normal weight and long-term macrovascular outcomes in people with type 2 diabetes in China: A retrospective study.
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70237.
    

    >> Share

    
    
30. ESMANN FVL, Heerfordt IM, Windfeld-Mathiasen J, Horwitz A, et al
    Anabolic androgenic steroid use and risk of diabetes mellitus in males.
    Diabetes Obes Metab. 2025 Nov 10. doi: 10.1111/dom.70283.
    

    >> Share

    
    

    
    Diabetologia

31. KUUSELA S, Koskenniemi JJ, Valtanen T, Pokka T, et al
    Islet autoimmunity and progression to type 1 diabetes in the Finnish DIPP study: comparison between genetically susceptible children with and without an affected first-degree relative.
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06573.
    

    >> Share

    
    
32. WU CY, Sharma A, Edwards JD, Liu PP, et al
    Cardiovascular effectiveness and safety of SGLT2 inhibitors vs DPP4 inhibitors by dementia status: a cohort study of older adults with diabetes.
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06595.
    

    >> Share

    
    
33. WONG FS, Pearson JA, Wen L
    Is the NOD mouse a good model for type 1 diabetes?
    Diabetologia. 2025 Nov 8. doi: 10.1007/s00125-025-06579.
    

    >> Share

    
    
34. JANSZ TT, Young KG, Hopkins R, McGovern AP, et al
    Precision medicine in type 2 diabetes: targeting SGLT2 inhibitor treatment for kidney protection.
    Diabetologia. 2025 Nov 9. doi: 10.1007/s00125-025-06577.
    

    >> Share

    
    
35. FORTEATH C, Merchant HJ, Kocherry C, Murdoch CE, et al
    Recurrent hypoglycaemia promotes cardiomyopathy and cardiac vulnerability in a rodent model of type 1 diabetes.
    Diabetologia. 2025 Nov 10. doi: 10.1007/s00125-025-06574.
    

    >> Share

    
    
36. PATEL SK, Ma CS, Fourlanos S, Greenfield JR, et al
    Clinical, immunogenetic and metabolic characteristics of autoantibody-negative and autoantibody-positive type 1 diabetes.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06580.
    

    >> Share

    
    
37. SHAH VN, Xu Y, Dabiri Y, Mohanadas HP, et al
    Association of HbA(1c) and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06599.
    

    >> Share

    
    
38. BERGDAHL E, Forsander G, Milkovic L, Sundberg F, et al
    Influence of glycaemic management and BMI on cardiac autonomic markers in children with type 1 diabetes: a prospective cohort study.
    Diabetologia. 2025 Nov 11. doi: 10.1007/s00125-025-06592.
    

    >> Share

    
    

    
    J Am Coll Cardiol

39. GALLI M, Benenati S, Laudani C, Simeone B, et al
    Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patients.
    J Am Coll Cardiol. 2025 Aug 19:S0735-1097(25)07492.
    

    >> Share

    
    
40. VERMA S, Catarig AM, Houlind K, Ludvik B, et al
    Sex Differences in Effectiveness of Semaglutide in Patients With Peripheral Artery Disease: The STRIDE Trial.
    J Am Coll Cardiol. 2025;86:1843-1857.
    

    >> Share

    
    

    
    J Am Soc Nephrol

41. MATSOUKAS C, Tomic TT, Tonelius P, Nunez-Duran E, et al
    Streamlining the Histopathological Workflow in Diabetic Kidney Disease with Artificial Intelligence.
    J Am Soc Nephrol. 2025 Nov 12. doi: 10.1681/ASN.0000000923.
    

    >> Share

    
    

    
    J Biol Chem

42. QI B, Chen Y, Lan Y, Lou Y, et al
    Metformin attenuates O-GlcNAc modification to improve renal function via AMPK/mTOR signaling in diabetic nephropathy.
    J Biol Chem. 2025 Nov 5:110909. doi: 10.1016/j.jbc.2025.110909.
    

    >> Share

    
    

    
    J Diabetes Complications

43. ZHAO C, Lu X, Deng X, Xia W, et al
    The effects of Bifidobacterium animalis subsp. lactis BLa80 on glycemic control and gut microbiota in patients with T2DM: a randomized, double-blind, placebo-controlled trial.
    J Diabetes Complications. 2025;39:109195.
    

    >> Share

    
    
44. AL-MHANNA SB, Franklin BA, Jakicic JM, Stamatakis E, et al
    Impact of aerobic exercise on cardiometabolic health in patients with diabesity: A systematic review and meta-analysis of randomized controlled trials.
    J Diabetes Complications. 2025;39:109203.
    

    >> Share

    
    
45. LIM S, Park CY, Jeong IK, Yoon JS, et al
    Empagliflozin versus metformin for glucose variability and metabolic outcomes in drug-naive type 2 diabetes: The EMPA-FIT study.
    J Diabetes Complications. 2025;40:109214.
    

    >> Share

    
    
46. AJONIJEBU TE, Mazibuko-Mbeje SE
    The miR-200 family in type 2 diabetes: therapeutic and biomarker perspectives.
    J Diabetes Complications. 2025;40:109211.
    

    >> Share

    
    
47. QIN R, Jiang C, Zhang M, Hou X, et al
    Prognostic value of non-alcoholic fatty liver disease, pericoronary fat attenuation index and computed tomography-derived fractional flow reserve in diabetic patients with suspected coronary artery disease.
    J Diabetes Complications. 2025;40:109216.
    

    >> Share

    
    
48. SLATER T, Hernandez Ibarburu G, Drebert Z, Henson J, et al
    Age at type 2 diabetes diagnosis and risk of cancer: Cohort study in over 1 million individuals from the TriNetX US Collaborative Network.
    J Diabetes Complications. 2025;40:109210.
    

    >> Share

    
    

    
    J Hypertens

49. LI X, Yang A, Liu X, Xu S, et al
    Screening of the key single nucleotide polymorphisms in type 2 diabetes mellitus complicated with lower extremity arterial disease by machine learning.
    J Hypertens. 2025 Nov 7. doi: 10.1097/HJH.0000000000004164.
    

    >> Share

    
    

    
    JAMA

50. STAPLIN N, Roddick AJ, Neuen BL, Anker SD, et al
    Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis.
    JAMA. 2025 Nov 7:e2520835. doi: 10.1001/jama.2025.20835.
    

    >> Share

    
    

    
    Nutr Metab (Lond)

51. FU Z, Chen Z, Bian S, Li L, et al
    Association of fructose-1,6-diphosphatase 1 with the progression of diabetic kidney disease.
    Nutr Metab (Lond). 2025;22:139.
    

    >> Share

    
    

    
    Ophthalmology

52. DO DV, Wykoff CC, Sivaprasad S, Brown DM, et al
    Intravitreal Aflibercept 8 mg for Diabetic Macular Edema: 96-Week Results from the Randomized Phase 2/3 PHOTON Trial.
    Ophthalmology. 2025 Nov 10:S0161-6420(25)00707.
    

    >> Share

    
    

    
    Pediatr Diabetes

53. NAZZAL B, Harazni L, Aqtam I, Anabtawi R, et al
    Lived Experiences of Coping With Type 1 Diabetes Among Palestinian Youth: A Qualitative Study.
    Pediatr Diabetes. 2025;2025:9014326.
    

    >> Share

    
    

    
    PLoS One

54. SUGIURA-ROTH Y, Himeno T, Asano-Hayami E, Asada-Yamada Y, et al
    The DR score in RETeval electroretinogram system facilitates expeditious and uncomplicated early detection and assessment of diabetic polyneuropathy in clinical practice.
    PLoS One. 2025;20:e0336117.
    

    >> Share

    
    
55. ANDARGE BD, Hayelom DH, Degualem SM, Bezie HE, et al
    Chronic complications among patients with type 2 diabetes in Southern Ethiopia.
    PLoS One. 2025;20:e0336666.
    

    >> Share

    
    
56. MARTINIAKOVA M, Soltesova Prnova M, Kovacova V, Mondockova V, et al
    Insufficient impact of the aldose reductase inhibitor cemtirestat on the skeletal system in type 2 diabetic rat model.
    PLoS One. 2025;20:e0336508.
    

    >> Share

    
    
57. LIM S, Kim JH, Hong SJ, Cha JJ, et al
    Efficacy and safety of polymer-free amphilimus-eluting stent in patients with and without diabetes mellitus: A prospective, multicenter observational study.
    PLoS One. 2025;20:e0336017.
    

    >> Share

    
    
58. HUNDAHL A, Jespersen LN, Sildorf SM, Lindkvist EB, et al
    Fear of hypoglycemia and its association with well-being, metabolic outcomes, and psychological health: A cross-sectional study in Danish adolescents with type 1 diabetes.
    PLoS One. 2025;20:e0334243.
    

    >> Share

    
    
59. NEUPERDT L, Du Y, Nubel J, Hapke U, et al
    Higher predicted type 2 diabetes risk is associated with worse mental health and self-rated general health among adults without known diabetes in Germany - Results of the nationwide population-based study GEDA 2022.
    PLoS One. 2025;20:e0336019.
    

    >> Share

    
    
60. ANDERSSON-HALL U, Nord AB, Malmodin D, Holmang A, et al
    Metabolomics and glucose tolerance in pregnancy and postpartum: The PONCH study.
    PLoS One. 2025;20:e0335708.
    

    >> Share

    
    

    
    Retina

61. SAHARE H
    Diabetic retinopathy phenotypes on ultrawide field retinal imaging in an Indian population.
    Retina. 2025 Nov 3. doi: 10.1097/IAE.0000000000004720.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share